Mallinckrodt PLC (NYSE:MNK) 2019 Q1 Sentiment Report

Sentiment for Mallinckrodt PLC (NYSE:MNK)

Mallinckrodt PLC (NYSE:MNK) institutional sentiment decreased to 1.16 in Q1 2019. Its down -0.22, from 1.38 in 2018Q4. The ratio turned negative, as 122 active investment managers increased or opened new holdings, while 105 decreased and sold stakes in Mallinckrodt PLC. The active investment managers in our partner’s database now possess: 89.26 million shares, down from 90.47 million shares in 2018Q4. Also, the number of active investment managers holding Mallinckrodt PLC in their top 10 holdings decreased from 2 to 0 for a decrease of 2. Sold All: 25 Reduced: 80 Increased: 73 New Position: 49.

Mallinckrodt public limited company develops, makes, markets, and distributes branded and generic specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. The company has market cap of $387.22 million. The companyÂ’s Specialty Brands segment markets branded pharmaceutical products for autoimmune and rare diseases, including the specialty areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and hemostasis products, and central nervous system drugs. It currently has negative earnings. This segment offers Acthar, an injectable drug for various indications, such as neurology, rheumatology, nephrology, and pulmonology; Ofirmev, an intravenous formulation of acetaminophen for pain management; Inomax for inhalation; Therakos, an immunotherapy treatment platform; and Exalgo, a form of hydromorphone.

The stock decreased 4.74% or $0.23 during the last trading session, reaching $4.62. About 1.95 million shares traded. Mallinckrodt plc (NYSE:MNK) has declined 71.18% since August 14, 2018 and is downtrending. It has underperformed by 71.18% the S&P500.

Armistice Capital Llc holds 1.78% of its portfolio in Mallinckrodt plc for 1.50 million shares. Schneider Capital Management Corp owns 247,199 shares or 1.23% of their US portfolio. Moreover, Hussman Strategic Advisors Inc. has 0.88% invested in the company for 165,000 shares. The Massachusetts-based Bogle Investment Management L P De has invested 0.71% in the stock. Merian Global Investors (Uk) Ltd, a United Kingdom-based fund reported 2.18 million shares.

Since January 1, 0001, it had 3 insider purchases, and 0 insider sales for $87,358 activity.

Mallinckrodt plc (NYSE:MNK) Ratings Coverage

Ratings analysis reveals 25% of Mallinckrodt’s analysts are positive. Out of 8 Wall Street analysts rating Mallinckrodt, 2 give it “Buy”, 0 “Sell” rating, while 6 recommend “Hold”. The lowest target is $900 while the high is $42. The stock’s average target of $24.25 is 424.89% above today’s ($4.62) share price. MNK was included in 15 notes of analysts from February 26, 2019. As per Thursday, February 28, the company rating was maintained by Morgan Stanley. The rating was maintained by Canaccord Genuity with “Buy” on Monday, March 18. The firm has “Buy” rating given on Tuesday, March 5 by Cantor Fitzgerald. The firm earned “Buy” rating on Tuesday, February 26 by Cantor Fitzgerald. Piper Jaffray downgraded the stock to “Neutral” rating in Friday, May 31 report. As per Wednesday, February 27, the company rating was maintained by Canaccord Genuity. The rating was maintained by Mizuho on Tuesday, February 26 with “Hold”. On Tuesday, March 12 the stock rating was maintained by Canaccord Genuity with “Buy”. Piper Jaffray maintained the shares of MNK in report on Wednesday, February 27 with “Buy” rating. On Wednesday, May 22 the stock rating was downgraded by Jefferies to “Hold”.

More notable recent Mallinckrodt plc (NYSE:MNK) news were published by: which released: “Is Mallinckrodt plc’s (NYSE:MNK) CEO Paid At A Competitive Rate? – Yahoo Finance” on July 22, 2019, also with their article: “Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc – Yahoo Finance” published on August 14, 2019, published: “Bristol-Myers Squibb Stock Has Upside — But Mind the Risks – Nasdaq” on August 12, 2019. More interesting news about Mallinckrodt plc (NYSE:MNK) were released by: and their article: “Glancy Prongay & Murray LLP Announces Investigation on Behalf of Mallinckrodt plc Investors (MNK) – Yahoo Finance” published on August 08, 2019 as well as‘s news article titled: “Is Mallinckrodt plc (MNK) A Good Stock To Buy? – Yahoo Finance” with publication date: April 29, 2019.

Mallinckrodt plc (NYSE:MNK) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.